What are the recommended pre‑operative endocrine management steps for patients with diabetes mellitus, hypothyroidism, hyperthyroidism, adrenal insufficiency, and pheochromocytoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Preoperative Endocrinologic Management

Pheochromocytoma

All patients with pheochromocytoma or secreting paraganglioma must receive preoperative alpha-blockade for at least 10-14 days before surgery to prevent hypertensive crises and arrhythmias. 1

Alpha-Blockade Protocol

  • First-line treatment is alpha-adrenergic blockade using phenoxybenzamine (non-competitive α-blocker) starting at 10 mg twice daily with dose adjustments every 2-4 days, or alternatively doxazosin (competitive selective α1-blocker) which may have fewer side effects 1
  • Blood pressure targets: <130/80 mmHg supine and systolic BP preferably >90 mmHg upright 1
  • If target BP not achieved: add calcium channel blockers (nifedipine slow release) or metyrosine 1
  • Beta-blockade is indicated only for tachyarrhythmias and must never be started before alpha-blockade to avoid unopposed alpha-stimulation 1
  • Constipation should be treated or prevented as part of preoperative preparation 1

Adrenal Insufficiency and Glucocorticoid Excess

In all patients with glucocorticoid excess (either overt or subclinical), hydrocortisone 150 mg/day must be administered during surgery and postoperatively to prevent adrenal crisis. 1

Stress-Dose Glucocorticoid Protocol

  • Intraoperative: Hydrocortisone 100 mg IV at induction followed by continuous infusion of 200 mg/24 hours 2
  • Alternative regimen: Hydrocortisone 50 mg IV/IM every 6 hours 2
  • Postoperative: Continue IV hydrocortisone 200 mg/24 hours until patient can take oral medications 2
  • Once oral intake established: Double the usual oral hydrocortisone replacement dose for 48 hours for uncomplicated recovery 2
  • For major or complicated surgery: Continue doubled oral doses for up to one week before tapering to maintenance 2

Special Considerations for Glucocorticoid Management

  • Patients on chronic glucocorticoids: The evidence for high-dose supplementation is sparse, but err on the side of administering stress-dose steroids if there is any doubt, as short-term glucocorticoid administration has no long-term adverse consequences 2
  • Patients with CYP3A4-inducing drugs or obesity: Maintain high index of suspicion for adrenal crisis and consider continuous infusion to reduce decompensation risk 1
  • Etomidate use: Single induction doses do not require additional supplementation, though clinical judgment is required 1

Early Recognition of Impending Adrenal Crisis

  • Cardinal signs (may be late): Volume-resistant hypotension 1
  • Earlier warning signs include: non-specific malaise, somnolence, obtunded consciousness, cognitive dysfunction, orthostatic hypotension (check sitting and supine BP), hyponatremia (though not always present), and persistent pyrexia 1
  • Do not reduce or withdraw steroid supplementation while patient is pyrexial 1

Diabetes Mellitus

Perioperative glycemic control has the strongest association with postsurgical outcomes in diabetic patients. 3

Preoperative Optimization

  • Assess current glycemic control and adjust insulin and non-insulin diabetic medications based on type of diabetes, insulin regimen, and predisposition to hyperglycemia or hypoglycemia 3
  • Minimize fasting period and prioritize diabetic patients on routine surgical lists 1
  • Children with adrenal insufficiency and diabetes require frequent blood glucose monitoring as they are more vulnerable to glycemic control problems than adults 1

Perioperative Glucose Management

  • Maintenance of normal blood glucose in the perioperative period benefits both diabetic and non-diabetic patients 4
  • Monitor for hypoglycemia after pheochromocytoma resection due to sudden reduction in catecholamine levels 1, 5

Thyroid Disease

Patients with thyroid dysfunction can safely undergo operations unless they have untreated hyperthyroidism or severe hypothyroidism. 3

Hyperthyroidism

  • Untreated hyperthyroidism is a contraindication to elective surgery due to risk of thyroid storm, which is associated with significant perioperative morbidity and mortality 4, 6
  • Achieve euthyroid state preoperatively before proceeding with elective procedures 6

Hypothyroidism

  • Severe hypothyroidism increases perioperative morbidity and mortality and should be treated before elective surgery 4, 6
  • Mild to moderate hypothyroidism generally does not require delay of surgery 6, 3

Pediatric Considerations

Children with adrenal insufficiency require special attention to prevent hypoglycemia and adrenal crisis. 1

Pediatric Glucocorticoid Protocol

  • Bolus hydrocortisone at induction followed by either immediate continuous infusion OR subsequent four-hourly IV boluses postoperatively 1
  • Dosing based on age and body weight with frequent blood glucose monitoring 1
  • Minimize fasting period and prioritize on surgical lists 1

Obstetric Patients

Pregnant women with adrenal insufficiency may require higher maintenance doses during later stages of pregnancy (from 20th week onwards). 1

Labor and Delivery Protocol

  • At onset of labor: Hydrocortisone 100 mg IV 1
  • During labor: Either continuous IV infusion of hydrocortisone 200 mg/24 hours OR 50 mg IM every 6 hours until after delivery 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Postoperative Corticosteroid Management in Pituitary Adenoma Surgery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Assessment and therapy of selected endocrine disorders.

Anesthesiology clinics of North America, 2004

Guideline

Postoperative Management of Bilateral Adrenalectomy for Pheochromocytoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Surgery in the patient with endocrine dysfunction.

The Medical clinics of North America, 2009

Related Questions

What is the appropriate perioperative endocrine assessment and management for an adult undergoing surgery, including diabetes, hypothyroidism, hyperthyroidism, adrenal insufficiency, pheochromocytoma, Cushing’s syndrome, and calcium/phosphate metabolism disorders?
What are the Endocrine Society's recommendations for managing endocrine disorders?
What are the diagnostic and treatment approaches for common endocrinological disorders?
What are the perioperative and postoperative management strategies for patients with endocrine pathologies undergoing surgery?
Is a patient with elevated Thyroid-Stimulating Hormone (TSH) level and normal Free T4 (FT4) after thyroidectomy for medullary thyroid carcinoma fit for iliac mass excision under anesthesia from an endocrine perspective?
In a young to middle‑aged man with a prior normal semen analysis of about 60 million sperm per milliliter and a serum follicle‑stimulating hormone of 9.9 IU/L measured two months later, how likely is progression to azoospermia if testicular atrophy is present?
In an elderly patient with lymphoma and immunosuppression, what is the normal red blood cell count in cerebrospinal fluid obtained by lumbar puncture?
What are the next investigations for a patient with normal serum cortisol who is suspected of iatrogenic Cushing's syndrome?
How should symptomatic ventricular premature complexes be managed?
In a patient with heart failure who has a weight gain of 4 kg and pneumonia on chest X‑ray, should I increase her furosemide (Lasix) dose?
Which parameter is better for determining whether an anemia is microcytic, normocytic, or macrocytic on a complete blood count: mean corpuscular volume (MCV) or mean corpuscular hemoglobin (MCH)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.